Finnish startup uses the funding to develop next-generation implants for correcting skeletal deformities
Synoste Oy, a Helsinki and Düsseldorf based medical device company is developing next-generation implantable devices based on their unique and proprietary technology platform. The company has now raised a seed-round of € 0.8 M to advance the development of its first product aimed at the limb lengthening market.
The seed round can be increased up to € 1.2 M upon reaching certain milestones and is supported by TEKES research funding with additional approx. € 1.6 M. High-Tech Gründerfonds (HTGF), Finnvera and Lifeline Ventures co-led the round and were joined by the existing Business Angels and Tekes – the Finnish Funding Agency for Technology and Innovation.
More about the investment: www.en.high-tech-gruenderfonds.de
